Cohort of STEMI Patients 2 - Trial NCT05794022
Access comprehensive clinical trial information for NCT05794022 through Pure Global AI's free database. This phase not specified trial is sponsored by Hospices Civils de Lyon and is currently Recruiting. The study focuses on Myocardial Infarction. Target enrollment is 100 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Hospices Civils de Lyon
Timeline & Enrollment
N/A
May 03, 2023
Jun 03, 2029
Primary Outcome
Research of potential new markers
Summary
ST-segment elevation myocardial infarction (STEMI) is an acute condition that accounts for
 75% of sudden deaths in adults over 35 years of age and more than half of all cases of
 chronic heart failure. However, the mechanism of myocardial infarction remains poorly
 understood. At present, there is no national information system for myocardial infarction, as
 there is for other diseases such as multiple sclerosis (OFSEP cohort).
 
 The purpose of this cohort is to enable studies and research projects to be carried out on
 the descriptive epidemiology of myocardial infarction, monitoring of patients undergoing
 treatment (safety, efficacy), quality of life and functional consequences of infarction, and
 research into new biological and imaging prognostic biomarkers. Its general objective is to
 provide researchers, hospital practitioners, medical interns, academics or industrialists
 with a quality epidemiological tool for research.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05794022
Non-Device Trial